Literature DB >> 7798984

Chronic idiopathic axonal polyneuropathy: a five year follow up.

N C Notermans1, J H Wokke, Y van der Graaf, H Franssen, G W van Dijk, F G Jennekens.   

Abstract

Seventy five patients with chronic idiopathic axonal polyneuropathy (CIAP) were studied for five years. The standardised and quantified neurological examination shows that progression of CIAP is slow, and handicap, if present, is not severe. During the follow up period a definite cause of the neuropathy was found in only four patients (two hereditary motor and sensory neuropathy type 2, one sensory chronic inflammatory demyelinating polyneuropathy, one alcoholic neuropathy). At the end of the follow up CIAP was not related to malignancy or gammopathy. Routine repetition of laboratory tests was not informative and these tests should be performed on clinical grounds only.

Entities:  

Mesh:

Year:  1994        PMID: 7798984      PMCID: PMC1073236          DOI: 10.1136/jnnp.57.12.1525

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

Review 2.  Paraneoplastic vasculitic neuropathy: a treatable neuropathy.

Authors:  S J Oh; R Slaughter; L Harrell
Journal:  Muscle Nerve       Date:  1991-02       Impact factor: 3.217

3.  Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients.

Authors:  N C Notermans; J H Wokke; H Franssen; Y van der Graaf; M Vermeulen; L H van den Berg; P R Bär; F G Jennekens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

4.  Subacute sensory neuropathy: a remote effect of carcinoma.

Authors:  M S Horwich; L Cho; R S Porro; J B Posner
Journal:  Ann Neurol       Date:  1977-07       Impact factor: 10.422

5.  Chronic demyelinating neuropathy with IgM-producing lymphocytes in peripheral nerve and delayed appearance of "benign" monoclonal gammopathy.

Authors:  J Julien; C Vital; J M Vallat; A Lagueny; X Ferrer; M J Leboutet
Journal:  Neurology       Date:  1984-10       Impact factor: 9.910

6.  "Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy.

Authors:  S J Oh; J L Joy; R Kuruoglu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

7.  Intensive evaluation of referred unclassified neuropathies yields improved diagnosis.

Authors:  P J Dyck; K F Oviatt; E H Lambert
Journal:  Ann Neurol       Date:  1981-09       Impact factor: 10.422

8.  Chronic polyneuropathy of undetermined cause.

Authors:  J G McLeod; R R Tuck; J D Pollard; J Cameron; J C Walsh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

9.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

  9 in total
  25 in total

Review 1.  Immunological mechanisms in paraneoplastic peripheral neuropathy.

Authors:  J C Antoine
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Peripheral neuropathy.

Authors:  Richard A C Hughes
Journal:  BMJ       Date:  2002-02-23

Review 3.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

4.  Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy.

Authors:  Wei Wang; Chen Wang; D Brian Dawson; Erik C Thorland; Patrick A Lundquist; Bruce W Eckloff; Yanhong Wu; Saurabh Baheti; Jared M Evans; Steven S Scherer; Peter J Dyck; Christopher J Klein
Journal:  Neurology       Date:  2016-04-13       Impact factor: 9.910

5.  Lymphoma, paraproteinaemia, and neuropathy.

Authors:  J H Wokke; J H Morris; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

6.  Response to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy with only sensory symptoms.

Authors:  G W van Dijk; N C Notermans; H Franssen; P L Oey; J H Wokke
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

Review 7.  Chronic idiopathic axonal polyneuropathy: a systematic review.

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Channa Hewamadduma; Marios Hadjivassiliou
Journal:  J Neurol       Date:  2016-03-09       Impact factor: 4.849

Review 8.  Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy?

Authors:  N R Rosenberg; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

9.  Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP).

Authors:  Peter G Erdmann; Laurien L Teunissen; Frank R van Genderen; Nicolette C Notermans; Eline Lindeman; Paul J M Helders; Nico L U van Meeteren
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849

10.  Feasibility and cost efficiency of a diagnostic guideline for chronic polyneuropathy: a prospective implementation study.

Authors:  A F J E Vrancken; S Kalmijn; E Buskens; H Franssen; M Vermeulen; J H J Wokke; N C Notermans
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.